Cite
HARVARD Citation
Klener, P. et al. (2018). Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma. Hematological oncology. 36 (1), pp. 110-115. [Online].